Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00904033 · ClinicalTrials.gov registry record · Phase 2
Calcitriol, Physical Activity, and Bone Health in Cancer Survivors
A Phase 2 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 2
- Development phase
- 41
- Enrollment target
NCT00904033 is a Phase 2 study that has completed, run by University of Rochester. The registered enrollment target is 41 participants.
The verdict
NCT00904033, a Phase 2 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 41 participants
- Enrollment target
Study Summary
Both the calcitriol and exercise interventions are aimed at reducing fracture risk by maintaining proper bone density, thereby preventing osteoporotic/osteopenic conditions and increasing muscle mass. Both calcitriol and exercise are efficacious in maintaining proper bone health and muscle mass among the general population, but little research has been done on breast cancer patients and survivors. The combination of calcitriol and exercise, which function through different but similar mechanisms, could produce interactive effects in reducing fracture risk among breast cancer survivors. Hypothesis: A combination of calcitriol along with a structured home-based walking and progressive resistance exercise program will be efficacious in preventing bone resorption and in increasing bone formation among survivors of invasive breast cancer.
Interventions
- BEHAVIORAL Exercise
- DIETARY_SUPPLEMENT Multivitamin
- DRUG Calcitriol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2008-12-01 |
| Est. Completion | 2018-01-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00904033
The ClinicalTrials.gov registry entry for NCT00904033 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Exercise is the first listed.
NCT00904033 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00904033 about?
NCT00904033 is a clinical study titled "Calcitriol, Physical Activity, and Bone Health in Cancer Survivors". Both the calcitriol and exercise interventions are aimed at reducing fracture risk by maintaining proper bone density, thereby preventing osteoporotic/osteopenic conditions and increasing muscle mass. Both calcitriol and exercise are efficacious in maintaining proper bone health and muscle mass amon...
What is the current status of trial NCT00904033?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 41 participants. The study started on 2008-12-01. Estimated completion is 2018-01-01.
What interventions are being tested in trial NCT00904033?
The interventions under investigation include: Exercise (BEHAVIORAL), Multivitamin (DIETARY_SUPPLEMENT), Calcitriol (DRUG).
Who is sponsoring clinical trial NCT00904033?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.